In breast cancer, partial or total loss of E-cadherin expression correlates with loss of differentiation characteristics, acquisition of invasiveness, increased tumor grade, metastatic behavior and poor prognosis [8]. This evidence concerns the gene CDH1 and breast carcinoma.